May 15, 2019

The Connection between HPV Infection and Head and Neck Cancer

For years, the typical patient with cancer of the mouth and throat (oropharyngeal cancer) fit a “Marlboro Man” stereotype—a rugged, outdoorsy man who was a lifelong smoker with a history of alcohol use. But that is no longer true. Today, patients are younger. They often don’t use tobacco or alcohol—common risk factors for oropharyngeal cancer. Instead, human papillomavirus (HPV) infection is now responsible for more than 70% of cases.

Mar 01, 2019

Joining Forces to Eradicate HPV-Related Cancers

HPV vaccination rates still lag far behind other recommended vaccines, and Utah has one of the lowest rates in the nation. Only about 34 percent of Utah adolescents have completed the vaccine series, compared to the national average of 50 percent. Huntsman Cancer Institute is joining forces with experts across the country to change those statistics.

Jun 07, 2018

Huntsman Cancer Institute Partners with Nation’s Top Cancer Centers to Endorse Goal of Eliminating HPV Related Cancers in the United States

Nearly 80 million Americans — one out of every four people — are infected with human papillomavirus (HPV). And of those millions, more than 31,000 will be diagnosed with an HPV-related cancer this year. Despite those staggering figures and the availability of a vaccine to prevent the infections that cause these cancers, HPV vaccination remains low in the United States.

Aug 18, 2017

You Can’t Rain on My Parade, HPV

When I was a teenager, the HPV vaccine did not exist. I wish it had; I would have been grateful for its protection. And I have news for you, HPV. You messed with the wrong woman.

Apr 26, 2017

Four Things You Should Know about Oral Cancer

Oral cancer is a cancer that forms in tissues of the mouth or the oropharynx (the part of the throat at the back of the mouth). As part of Oral, Head, and Neck Cancer Awareness Month this April, here are four things you need to know about finding and preventing oral cancer.

Jan 10, 2017

Huntsman Cancer Institute Joins Nation’s Cancer Centers to Endorse Updated HPV Vaccine Recommendations

Recognizing a critical need to improve national vaccination rates for human papillomavirus (HPV), Huntsman Cancer Institute (HCI) at the University of Utah has united with each of the 69 National Cancer Institute (NCI)-designated cancer centers in support of recently revised recommendations from the Centers for Disease Control and Prevention (CDC).

Jan 27, 2016

NCI-designated Cancer Centers Urge HPV Vaccination for the Prevention of Cancer

Approximately 79 million people in the U.S. are currently infected with a human papillomavirus (HPV), according to the Centers for Disease Control and Prevention (CDC), and 14 million new infections occur each year. HPV is responsible for the vast majority of cervical cancers. HPV is also associated with cancers of the anus, mouth/throat, vagina, and penis. The CDC reports that each year in the U.S., 27,000 men and women are diagnosed with an HPV-related cancer. Even though many of these HPV-related cancers are preventable with a safe and effective vaccine, HPV vaccination rates across the United States remain low.